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ABSTRACT Currently, there is no agreed method available for broth microdilution
susceptibility testing of Haemophilus parasuis, one of the most important bacterial
pathogens in pig production. Therefore, the aim of this study was to develop a
method that could be easily performed by diagnostic laboratories and that appears
suitable for a harmonized susceptibility testing. Growth determinations using one
type strain and three ﬁeld isolates revealed no visible growth of H. parasuis in media
which have proven to be suitable for susceptibility testing of fastidious organisms.
Therefore, a new medium, cation-adjusted Mueller-Hinton broth (CAMHB) plus NADH
and sterile ﬁltered heat-inactivated chicken serum, was developed. The reproducibil-
ity of MICs obtained in this medium was evaluated and statistically analyzed, consid-
ering a model with two different variables (precondition of ﬁve identical MICs and
MIC mode accepting a deviation of 1 dilution step, respectively). No signiﬁcant dif-
ferences for both variables were seen between two time points investigated and be-
tween results obtained with the recently proposed test medium broth (TMB). Nearly
all MICs of quality control strains were in the acceptable range. Subsequently, 47 H.
parasuis isolates representing 13 serovars were tested with the newly developed me-
dium and TMB. Statistical analysis of all isolates and 15 antimicrobial agents and an-
timicrobial combinations showed no signiﬁcant difference between MICs obtained in
supplemented CAMHB and TMB. Because of a simpliﬁed implementation in routine
diagnostic and a lower chance of interference between medium components and
antimicrobial agents, supplemented CAMHB is recommended with an incubation
time of 24 h.
KEYWORDS broth microdilution, susceptibility testing, MICs, Haemophilus parasuis,
fastidious organism, TMB, supplemented CAMHB
Haemophilus parasuis is an abundant colonizer of the upper respiratory tract inswine (1). Although in H. parasuis endemic herds, young piglets are usually
protected by maternal immunity, several environmental stress factors may lead to
disease as well as infections of naive populations. The acute form of disease, Glässer’s
disease, is characterized by clinical signs of polyarthritis, polyserositis, meningitis, and
pneumonia (among others) and can lead to sudden death of animals, especially in
weaner pigs (2, 3). At least 15 different H. parasuis serovars have been identiﬁed so far,
with the most common serovars being 4 and 5 (4, 5).
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As antimicrobial agents are used for the treatment of disease, a reliable method for
susceptibility testing of the pathogen is essential. H. parasuis is a fastidious organism
which requires speciﬁc ingredients or supplements to achieve visible growth in broth,
and hence, media which are used to test rapidly growing bacteria are not adequate (6,
7). As a consequence, no validated and standardized method is available (7, 8), and
many diagnostic laboratories are currently unable to offer susceptibility testing of this
very important pathogen in pig production. However, a few studies investigated the
susceptibility status of H. parasuis isolates quantitatively by using media such as
veterinary fastidious medium (VFM) or Haemophilus test medium (HTM) for broth
microdilution susceptibility testing (7, 9–16). VFM is recommended in CLSI standard
VET01-A4 for susceptibility testing of Actinobacillus pleuropneumoniae and Histophilus
somni (17), while HTM and cation-adjusted Mueller-Hinton broth (CAMHB) supple-
mented with 2.5% to 5% lysed horse blood (LHB) are CLSI-approved broth media for the
testing of fastidious organisms, with HTM being recommended for Haemophilus inﬂu-
enzae and Haemophilus parainﬂuenzae (18). As it has been seen that VFM is not suitable
for all H. parasuis isolates, a broth microdilution susceptibility testing method with test
medium broth (TMB) has recently been proposed (7). TMB is a complex medium
consisting of 1% (wt/vol) Biosate peptone, 1% (wt/vol) sodium chloride, 0.1% (wt/vol)
starch, 0.1% (wt/vol) glucose, and 0.05% (wt/vol) yeast extract, which is supplemented
with 0.0025% (vol/vol) NADH, 0.0005% (vol/vol) thiamine HCl, 1% (vol/vol) sterile
ﬁltered heat-inactivated chicken serum, and 5% (vol/vol) oleic acid bovine albumin
complex. The oleic acid bovine albumin complex is composed of saline with 0.06%
(vol/vol) oleic acid and 5% (vol/vol) 0.05 N NaOH, which is ﬁnally enriched with 4.75%
(vol/vol) bovine serum albumin (7).
Therefore, this study was aimed at (i) comparatively analyzing the suitability of
different broth media for susceptibility testing of preferably a wide range of different
H. parasuis serovars and (ii) identifying a broth medium for a harmonized routine
diagnostic approach. For this, a new medium, CAMHB with a reduced content of
supplements, was developed and used for testing of 46 H. parasuis ﬁeld isolates,
including representatives of 13 serovars, in comparison to TMB. Subsequently, statis-
tical analysis was performed to examine the homogeneity of MIC data and to investi-
gate the difference between supplemented CAMHB and TMB. Hence, this study might
contribute to establish a standardized broth microdilution susceptibility testing
method for H. parasuis.
RESULTS
Growth of H. parasuis in broth media. To determine the adequacy of the broth
media for susceptibility testing, type strain DSM 21448 and three H. parasuis ﬁeld
isolates of serovars 5 (two isolates) and 14 (one isolate) were chosen. The isolates of
serovar 5 were included because this serovar is regarded as the most pathogenic H.
parasuis serovar in Germany. As well, two of the isolates (no. 24 of serovar 14 and 52
of serovar 5) were selected because they are extremely slow-growing isolates and
difﬁcult to culture. The growth curves from two independent experiments revealed that
all isolates showed almost consistent growth in VFM and TMB. However, in CAMHB plus
2.5% LHB and HTM, a decrease of the isolates in CFU values over time was detected
after only a few hours, except for type strain DSM 21448 (see Fig. S1 to S5 in the
supplemental material).
In addition, visible growth of 28 H. parasuis ﬁeld isolates of various serovars was
assessed in microtiter plates with and without antibiotic coating, and in agreement
with results from growth determination, no growth was detected in any of the wells
when HTM and CAMHB plus 2.5% LHB were used. With VFM, visible growth could be
detected only for seven isolates, although the H. parasuis type strain and all three ﬁeld
isolates showed a sufﬁcient increase in CFU/ml during growth curve determination.
However, MIC endpoints could be determined in VFM only for the type strain. In
contrast to these ﬁndings, visible growth of all tested H. parasuis isolates was detected
in microtiter plate wells while testing TMB.
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Supplemented CAMHB for susceptibility testing of H. parasuis. CAMHB enriched
with the four supplements used in TMB led to visible growth of H. parasuis isolates
tested in 96-well plates. The amount of growth in the wells was comparable to the
amount of growth in microtiter panels with TMB medium (Table 1). Using only three
supplements with CAMHB, tests revealed that NADH was essential for the growth of all
H. parasuis isolates and omitting one of the supplements thiamine, sterile ﬁltered
inactivated chicken serum, and O-A complex showed no difference in visible growth. To
further reduce the number of supplements, it was evaluated if growth of the H. parasuis
isolates varied when only two supplements were added to CAMHB. Results of these
experiments showed that supplementation of sterile ﬁltered inactivated chicken serum
or O-A complex is necessary to obtain visible growth of H. parasuis isolates in CAMHB
(Table 1). As O-A complex consists of two different components (oleic acid and bovine
serum albumin) and therefore is a complex supplement to prepare, sterile ﬁltered
inactivated chicken serum together with NADH was chosen to supplement CAMHB for
broth microdilution susceptibility testing of H. parasuis isolates. Finally, the recipe for
the supplemented CAMHB was CAMHB plus 0.0025% (vol/vol) NADH and 1% (vol/vol)
sterile ﬁltered heat-inactivated chicken serum.
Subsequently, colony count determinations during culturing of type strain DSM
21448 and three H. parasuis ﬁeld isolates in supplemented CAMHB were performed,
and adequate growth of all isolates could be detected (see Fig. S6 in the supplemental
material).
Control of different batches and producers. MICs of type strain DSM 21448 and
three ﬁeld isolates using two different batches and another two producers of NADH
and chicken serum showed comparable results after 24 h of incubation, with a
maximum deviation of one dilution step.
Test ranges of QC strains. To investigate the inﬂuence of test media on MICs of
quality control (QC) strains, broth microdilution susceptibility testing of four QC strains
was performed using TMB and supplemented CAMHB, although QC ranges have been
established in unsupplemented CAMHB or in VFM (Actinobacillus pleuropneumoniae).
Threefold-repeated susceptibility testing revealed that MICs from 261 out of 270 QC
strain-antimicrobial agent combinations were within acceptable ranges in both media
(17). The only exceptions for TMB were the combinations A. pleuropneumoniae with
gentamicin and A. pleuropneumoniae with the antibiotics gentamicin and penicillin in
supplemented CAMHB in all three repetitions.
TABLE 1 Supplementation of CAMHB and determination of visible growth of 15 H.
parasuis isolates
CAMHB supplementa
Visible growth
in microtiter
platesb
NADH
(0.0025%)
Heat-inactivated
chicken serum
(1%)
Thiamine
(0.0005%)
O-A
complex
(5%)
    
    
    
    
    
    
    
    
    
    
    
    
    
a, supplement was added to CAMHB; , supplement was not added to CAMHB.
bThe following scheme was used to grade the visible growth of H. parasuis: , excellent growth (size of
buttons is comparable to the size of buttons with TMB); , fair growth; , poor growth; , no growth.
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Homogeneity of H. parasuis MICs. To assess the homogeneity of MICs obtained
with supplemented CAMHB and TMB with two different incubation times, the H.
parasuis type strain and the two ﬁeld isolates included in the growth curve determi-
nations were used. As the third H. parasuis ﬁeld isolate (no. 52) showed visible growth
only after 48 h in supplemented CAMHB, this isolate was omitted from this analysis. The
MIC determinations were repeated in ﬁve independent experiments. A panel of 21
antimicrobials and antimicrobial combinations was included in the repeated tests, and
two different incubation times, 16 to 20 h and 24 h, were analyzed. Results from the
repeated tests are shown in Tables 2 and 3. The multifactorial logistic regression
analysis with the 11 antibiotics fulﬁlling statistical requirements revealed that no
signiﬁcant inﬂuence of the different incubation times on MICs obtained in both media
was observed, either for the evaluation of data by exact MIC agreement (P  0.5165)
or by essential MIC agreement accepting a deviation of 1 dilution step (P  0.1913).
For the exact MIC agreement, the percentage of homogeneous MICs was 25.8% after
16 to 20 and 30.3% after 24 h of incubation. The percentages were 92.4% after 16 to
20 h and 97.0% after 24 h of incubation for the essential MIC agreement. When
comparing the homogeneity of MICs (i.e., all ﬁve MICs were identical) obtained in the
two media, supplemented CAMHB showed 27.3% homogeneous MICs, while TMB gave
a ﬁgure of 28.8%, with the difference not being signiﬁcant (P  0.8282). For the MIC
mode accepting a deviation of 1 dilution step, 90.9% of MICs showed homogeneous
MICs for supplemented CAMHB, while 98.5% of the MICs were homogeneous for TMB
(P  0.0567). No signiﬁcant inﬂuence on the homogeneity of MICs was seen for the
exact (P  0.5584) and the essential MIC agreement (P  0.9954) for the antimicrobial
agents. In contrast, the bacterial strains had a signiﬁcant inﬂuence on the homogeneity
of MICs for the exact MIC agreement (P 0.0005), whereas no signiﬁcant inﬂuence was
seen for the essential MIC agreement (P  0.4757).
Results from MIC determinations of H. parasuis ﬁeld isolates. Using both media,
supplemented CAMHB and TMB, there was no difﬁculty in determining visible growth
of all 47 H. parasuis isolates in the wells of microtiter plates and reading of MIC
TABLE 2 Homogeneity of MICs obtained with supplemented CAMHB by using two different incubation times
Antimicrobial
agentb
Incubation time, 16–20 h Incubation time, 24 h
Deviation from MIC modea
Exact MIC
agreement of
isolates (%)
Essential MIC
agreement of
isolates (%)
Deviation from MIC modea
Exact MIC
agreement of
isolates (%)
Essential MIC
agreement of
isolates (%)3 2 1 0 1 2 3 3 2 1 0 1 2 3
AMP 2 11 2 73.3 100.0 2 11 2 73.3 100.0
AUG 3 12 80.0 100.0 3 12 80.0 100.0
CEQ 15 100.0 100.0 2 13 86.7 100.0
CIP 15 100.0 100.0 15 100.0 100.0
COL 2 9 4 60.0 100.0 3 10 2 66.7 100.0
DOX 5 10 66.7 100.0 3 12 80.0 100.0
ENRO 15 100.0 100.0 14 1 93.3 100.0
FFN 13 2 86.7 100.0 1 14 93.3 100.0
FOP 15 100.0 100.0 2 13 86.7 100.0
FOT 1 14 93.3 100.0 1 14 93.3 100.0
GEN 1 14 93.3 100.0 13 2 86.7 100.0
IMI 12 3 80.0 100.0 2 11 2 73.3 100.0
NAL 1 13 1 86.7 100.0 1 13 1 86.7 100.0
NEO 2 12 1 80.0 100.0 2 11 2 73.3 100.0
PEN 2 9 3 1 60.0 93.3 1 2 2 8 2 53.3 80.0
STR 3 4 8 53.3 80.0 3 12 80.0 100.0
SXT 1 10 4 66.7 100.0 3 10 2 66.7 100.0
TET 1 4 10 66.7 93.3 2 11 2 73.3 100.0
TIA 2 4 6 3 40.0 86.7 1 9 3 2 60.0 86.7
TIL 1 14 93.3 100.0 1 11 3 73.3 100.0
XNL 15 100.0 100.0 15 100.0 100.0
aData fulﬁlling the criteria of the essential MIC agreement are in the gray area.
bAMP, ampicillin; AMC, amoxicillin-clavulanic acid; CIP, ciproﬂoxacin; COL, colistin; CQN, cefquinome; DOX, doxycycline; ENRO, enroﬂoxacin; FFN, ﬂorfenicol; FOP,
cefoperazone; FOT, cefotaxime; GEN, gentamicin; IMI, imipenem; MAR, marboﬂoxacin; NAL, nalidixic acid; NEO, neomycin; PEN, penicillin; STR, streptomycin; SXT,
trimethoprim-sulfamethoxazole; TET, tetracycline; TIA, tiamulin; TIL, tilmicosin; XNL, ceftiofur.
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endpoints was feasible. Control of inoculum density showed the required inoculum size
of 5  105 CFU/ml. The MICs of the isolates are presented in Table 4 and in Table S1
in the supplemental material.
Considering the results from supplemented CAMHB, a bimodal distribution of MICs
was detected for the antimicrobial agents ampicillin, ciproﬂoxacin, colistin, doxycycline,
enroﬂoxacin, nalidixic acid, neomycin, penicillin, streptomycin, tetracycline, and tilmi-
cosin, whereas a unimodal distribution was determined for the remaining antibiotics
tested. However, the broadest distribution of MICs was found for the antibiotic com-
bination trimethoprim-sulfamethoxazole. As there are no CLSI-recommended break-
points for H. parasuis isolates available, a classiﬁcation of isolates as susceptible or
resistant was not possible. However, the majority of isolates proved to have very low
MIC50s and MIC90s (equal to or below 0.5 g/ml) for all -lactam antimicrobials, and
only a couple of isolates showed elevated MICs in comparison to the majority of isolates
(Table 4).
Comparative analysis of MICs. For simpliﬁed interpretability of MICs, an incubation
time of 24 h was chosen for comparative analysis. Comparing MIC50s and MIC90s of
supplemented CAMHB and TMB, slight differences were detected. Five out of 21 MIC50s
were up to two dilution steps higher when using TMB, while it was seen that one MIC50
was one dilution step lower. The MIC90s of cefquinome, ﬂorfenicol, streptomycin, and
tiamulin differed by one dilution step, with lower values detected while using TMB.
The entire comparison of MICs of 47 isolates and 15 antimicrobial agents fulﬁlling
the inclusion criteria for statistical analysis, independent of MIC50s and MIC90s, showed
no signiﬁcant difference (P  0.2076) between the two media. However, statistical
analysis of individual antimicrobial agents showed signiﬁcant differences of MICs
between the two media for the following antimicrobial agents, which were signiﬁcantly
higher in TMB for the antimicrobials colistin (P  0.0038), gentamicin (P  0.0006), and
neomycin (P  0.0001) and signiﬁcantly lower in TMB for doxycycline (P  0.0010),
ﬂorfenicol (P  0.0003), streptomycin (P  0.0127), and tiamulin (P  0.0110).
TABLE 3 Homogeneity of MICs obtained with TMB by using two different incubation timesa
Antimicrobial
agentb
Incubation time, 16–20 h Incubation time, 24 h
Deviation from MIC mode
Exact MIC
agreement of
isolates (%)
Essential MIC
agreement of
isolates (%)
Deviation from MIC mode
Exact MIC
agreement of
isolates (%)
Essential MIC
agreement of
isolates (%)3 2 1 0 1 2 3 3 2 1 0 1 2 3
AMP 3 12 80.0 100.0 1 13 1 86.7 100.0
AUG 14 1 93.3 100.0 12 3 80.0 100.0
CEQ 1 12 2 80.0 100.0 1 12 2 80.0 100.0
CIP 15 100.0 100.0 15 100.0 100.0
COL 13 2 86.7 100.0 1 13 1 86.7 100.0
DOX 1 14 93.3 100.0 14 1 93.3 100.0
ENRO 15 100.0 100.0 15 100.0 100.0
FFN 1 13 1 86.7 100.0 1 14 93.3 100.0
FOP 15 100.0 100.0 14 1 93.3 100.0
FOT 13 2 86.7 100.0 13 2 86.7 100.0
GEN 1 2 10 2 66.7 93.3 1 12 2 80.0 100.0
IMI 13 2 86.7 100.0 14 1 93.3 100.0
NAL 2 10 3 66.7 100.0 12 3 80.0 100.0
NEO 2 10 3 66.7 100.0 2 11 2 73.3 100.0
PEN 2 2 10 1 66.7 86.7 11 4 73.3 100.0
STR 4 10 1 66.7 100.0 1 12 2 80.0 100.0
SXT 1 12 2 80.0 100.0 13 2 86.7 100.0
TET 14 1 93.3 93.3 13 1 1 86.7 93.3
TIA 3 9 3 60.0 100.0 1 12 2 80.0 100.0
TIL 3 10 1 1 66.7 93.3 1 11 3 73.3 100.0
XNL 15 100.0 100.0 15 100.0 100.0
aData fulﬁlling the criteria of the essential MIC agreement are in the gray area.
bAMP, ampicillin; AMC, amoxicillin-clavulanic acid; CIP, ciproﬂoxacin; COL, colistin; CQN, cefquinome; DOX, doxycycline; ENRO, enroﬂoxacin; FFN, ﬂorfenicol; FOP,
cefoperazone; FOT, cefotaxime; GEN, gentamicin; IMI, imipenem; NAL, nalidixic acid; NEO, neomycin; PEN, penicillin; STR, streptomycin; SXT,
trimethoprim-sulfamethoxazole; TET, tetracycline; TIA, tiamulin; TIL, tilmicosin; XNL, ceftiofur.
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DISCUSSION
In a recent study, VFM was reported to be unsuitable for broth microdilution
susceptibility testing of Australian H. parasuis isolates, and TMB was proposed (7).
However, currently there is no standardized method available in the CLSI guidelines for
H. parasuis and the usage of different methods can lead to variable MIC results and
poor comparability of results (17, 19). Furthermore, due to high losses on pig farms
worldwide caused by H. parasuis (20), ﬁnding an appropriate and agreed-upon method
of susceptibility testing for this important veterinary pathogen is urgently required.
In this study, colony count determinations during culturing in four different media
detected growth of H. parasuis ﬁeld isolates in VFM and TMB, whereas only growth of
type strain DSM 21448 could be detected in HTM and CAMHB plus 2.5% LHB. Surpris-
ingly, visible growth in microtiter plate wells was detected in only 25% of the tested H.
parasuis ﬁeld isolates cultured in VFM. The reason why no visible growth in microtiter
plates was seen in VFM, although growth could be obtained in growth curves using
culture enumeration, is not clear. The absence of visible growth in CAMHB plus 2.5%
LHB, HTM, and VFM indicate that all three media are not suitable for broth microdilu-
tion susceptibility testing of H. parasuis isolates. In contrast, TMB promotes the growth
of all H. parasuis isolates from Germany and even slow-growing isolates, which were
difﬁcult to culture on agar plates, showed visible growth in microtiter plate wells. TMB
is not commercially available, and preparing the medium in routine diagnostic labo-
ratories is a markedly complex task, as the medium consists of several components and
supplements. Additionally, there are issues about batch-to-batch reproducibility and a
low content of inhibitors that affect antimicrobial agents that still have to be addressed.
If a nonapproved medium is used for broth microdilution susceptibility testing, valida-
tion of the medium has to undergo an extensive procedure. One important factor is the
applicability of QC strains and their MICs within a speciﬁed range. In this study, nearly
all MICs of QC strains were in the acceptable range with both media used, although the
QC ranges have been established in media other than TMB or supplemented CAMHB,
TABLE 4MIC distribution of 47 H. parasuis isolates after 24 h of incubation in supplemented CAMHB
Antimicrobial agent
No. of isolates with indicated MIC (g/ml) after 24 h of incubationa
0.008 0.015 0.03 0.06 0.12 0.25 0.5 1 2 4 8 16 32 64 128 256 512 1,024 MIC50 MIC90
Ampicillin 17* 9 9 8 3 1 0.06 0.25
Amoxicillin-clavulanic
acid, 2:1 ratiob
6* 20 13 4 4 0.06 0.25
Ceftiofur 46* 1 0.03 0.03
Cefquinome 37* 5 3 2 0.015 0.06
Cefoperazone 47* 0.06 0.06
Cefotaxime 43* 3 1 0.015 0.015
Ciproﬂoxacin 39* 2 5 1 0.008 0.03
Colistin 1 25 11 3 2 2 3 0.06 2
Doxycycline 10 25 6 3 1 2 0.25 1
Enroﬂoxacin 28* 12 3 3 1 0.008 0.03
Florfenicol 6* 29 12 0.25 0.5
Gentamicin 1 6 26 14 1 2
Imipenem 4* 11 20 12 0.06 0.12
Nalidixic acid 7 29 3 2 4 1 1 1 16
Neomycin 1* 2 4 1 2 14 19 4 2 4
Penicillin 10* 7 8 4 13 3 1 1* 0.06 0.5
Streptomycin 1 3 13 18 6 1 1 4 16 128
Tiamulin 1 1 5 18 17 5 2 8
Tetracycline 1* 7 29 2 1 2 4 1 0.5 16
Tilmicosin 6 14 16 10 1 1 2
Trimethoprim-
sulfamethoxazole
(1:19)c
6* 4 1 6 6 12 5 2 4 1 0.5 4
aAsterisked numbers are the number of isolates with MICs equal to or higher or lower than concentrations of the tested range. The tested range of the antimicrobials
agents is represented in the white area.
bData represent the concentration of amoxicillin.
cData represent the concentration of trimethoprim.
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and therefore, it was not expected to have all MICs in the published ranges. It should
be noted that the QC strain A. pleuropneumoniae is also a fastidious bacterium, and
susceptibility testing in VFM medium according to CLSI document VET01-A4 is recom-
mended (17). This could be the reason for the deviation of a few MICs from the
acceptable range of the QC strain A. pleuropneumoniae. However, the results from QC
strains indicate that there is no effect of medium components on the activity of
antimicrobial agents.
A new medium was established for routine broth microdilution susceptibility testing
of H. parasuis, based on CAMHB and enriched with essential supplements (7, 21).
CAMHB was used since it is a validated and agreed medium for susceptibility testing
with an optimal rate of cations, showing high reproducibility of MIC data and being
recommended in CLSI document VET01-A4 for MIC determination of rapidly replicating
bacteria. It is also low in inhibitors for sulfonamides, trimethoprim and tetracycline.
Since supplementation of CAMHB with 2.5% LHB resulted in the absence of growth of
H. parasuis ﬁeld isolates, the essential supplements (NADH and sterile ﬁltered inacti-
vated chicken serum) from TMB were chosen to enrich CAMHB in the same concen-
trations as in TMB (7). Importantly, NADH-containing HTM is recommended in CLSI
document M07-A9 (18) for susceptibility testing of fastidious organism such as Hae-
mophilus inﬂuenzae and is therefore a CLSI-veriﬁed supplement.
Statistical analysis revealed that both incubation times tested had no inﬂuence on
the homogeneity of MICs. Due to the low growth rate of H. parasuis compared to other
rapidly replicating bacteria and few isolates showing weak growth after 16 to 20 h of
incubation, an incubation time of 24 h is suggested, which might be extended to 48 h
for isolates which show no growth after 24 h.
The supplemented CAMHB appears to be a suitable medium for broth microdilution
susceptibility testing of the majority of H. parasuis isolates from Germany. As the
medium had no signiﬁcant inﬂuence on the homogeneity of the MICs and although
TMB seems to support the growth of H. parasuis isolates slightly better, CAMHB
provides the advantage of a validated basic broth medium (17). Preparation of this
medium is less challenging and sensitive and could be used in routine diagnostic
laboratories.
Due to the lack of speciﬁc breakpoints for H. parasuis, a classiﬁcation of the 46 ﬁeld
isolates into the categories susceptible, intermediate, and resistant could not be
obtained, and percentages of resistances could therefore not be calculated. Neverthe-
less, bimodal distributions of MICs were indicative of the presence of nonwild type
isolates. In a study by Dayao et al., MIC50s and MIC90s of 97 H. parasuis isolates from
Australia were tested in TMB, and it was seen that comparable values with a maximum
of one dilution step difference were obtained for ampicillin, ﬂorfenicol, penicillin,
tetracycline, and trimethoprim-sulfamethoxazole. However, for tilmicosin, the MIC90
was four dilution steps higher than in the present study, indicating a difference in MIC
distribution of Australian and German isolates tested (7).
Conclusion. For broth microdilution susceptibility testing of H. parasuis, supple-
mented CAMBH and TMB have been shown to be most suitable. The use of both media
resulted in reproducible and comparable MICs, with MICs of quality control strains
being in the acceptable range for nearly all antimicrobial agents tested. Supplemented
CAMHB is recommended for routine diagnostics since it is based on an agreed-upon
and validated base medium, which is commercially available. For H. parasuis suscepti-
bility testing, an incubation time of 24 h is recommended. The proposed method
enables broth microdilution susceptibility testing of H. parasuis isolates in routine
diagnostics and might contribute to establishment of a standardized method for this
important veterinary pathogen.
MATERIALS AND METHODS
Bacterial isolates. H. parasuis type strain DSM 21448 (Leibniz-Institute DSMZ, Braunschweig, Ger-
many) and 46 H. parasuis ﬁeld isolates were used for the present study. The isolates originated from
diseased pigs and were collected at pig farms from different geographic regions in Germany between
2011 and 2013. All ﬁeld isolates were provided by diagnostic laboratories in Germany and included 25
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serotyped isolates of serovars 1 (n  2), 2 (n  2), 4 (n  2), 5 (n  2), 6 (n  2), 8 (n  2), 9 (n  1),
10 (n  2), 11 (n  2), 12 (n  2), 13 (n  2), 14 (n  2), and 15 (n  2). Isolates were cultured on
chocolate agar with 10% deﬁbrinated horse blood in ambient air at an incubation temperature of 35°C
2°C for 24 to 48 h. To conﬁrm that the ﬁeld isolates were H. parasuis, a PCR assay amplifying an 821-bp
internal fragment of the 16S small subunit rRNA gene was used as described earlier (20).
Growth curves. To compile growth curves, type strain DSM 21448 of H. parasuis and three ﬁeld
isolates of serovars 5 (2 isolates) and 14 (1 isolate) were used. Growth curves were performed in four
different broth media (HTM, TMB, VFM, and CAMHB plus 2.5% LHB), as these media have been proven
suitable for susceptibility testing of fastidious organisms (7, 10, 11, 21–23). In brief, isolates were grown
on chocolate agar for 24 to 48 h at 35°C  2°C in ambient air, colonies were suspended in 0.9% saline,
and the suspension was adjusted to an initial concentration of approximately 103 to 104 CFU/ml. Isolates
were cultured in a volume of 5 ml for 48 h at 35°C  2°C in ambient air without shaking, and the CFU
count per milliliter was determined by culture enumeration every 4 h (up to h 24) and 8 h (up to h 48),
respectively. The weighted average was calculated from agar plates containing between 5 and 200
CFU/ml.
Development of a modiﬁed broth medium. As TMB is not commercially available and to provide
an easier-to-prepare medium for routine diagnostic laboratories, a new medium based on CAMHB
(Oxoid, Wesel, Germany) was developed for broth microdilution susceptibility testing of H. parasuis. For
this purpose, which of the supplements of TMB were essential to provide sufﬁcient growth of preferably
all H. parasuis isolates and serovars was evaluated. CAMHB was taken as a basis since it is the
CLSI-approved medium of choice for susceptibility testing of commonly isolated pathogens. For sup-
plementation of CAMHB, the medium was ﬁrst tested with all TMB supplements, and then one
supplement at a time was removed. A list of all formulations tested is given in Table 1. Supplements were
added to CAMHB aseptically after autoclaving, and concentrations of supplements were equal to
concentrations used in TMB. As pH measurements showed values between pH 7.2 and 7.4, a pH
adjustment of the supplemented CAMHB was not necessary.
The necessity of the supplements was tested against a set of 15 H. parasuis isolates in 96-well
microtiter plates, and visible growth in the wells was determined (Table 1). NADH (-NAD, reduced form,
disodium salt) (Armin Baack, Schwerin, Germany, and Sigma-Aldrich, Seelze, Germany) and sterile ﬁltered
chicken serum (Bio&Sell, Feucht, Germany, and Pan-Biotech, Aidenbach, Germany) of two different
producers were veriﬁed by broth microdilution susceptibility testing with type strain DSM 21448 and the
three ﬁeld isolates with 21 antimicrobial agents.
Susceptibility testing. For broth microdilution susceptibility testing, customized 50-l/well micro-
titer plates (Sensititre, East Grinstead, UK) coated with vacuum-dried antibiotics were used. Testing
included 21 antimicrobial agents and antibiotic combinations (Table 5), four of which are currently not
licensed for food-producing animals and were included for comparison reasons (cefotaxime, ciproﬂoxa-
cin, imipenem, and nalidixic acid). Inoculum preparation and density, incubation conditions, and MIC
endpoint determinations for H. parasuis followed the recommendations given in CLSI documents
M07-A9 and VET01-A4 for rapidly replicating bacteria (17, 18). The direct colony suspension method was
used for inoculum preparation. In brief, colonies were selected from a 24-h agar plate, inoculated into
0.9% saline, and adjusted to a turbidity comparable to that of a 0.5 McFarland standard. The saline
suspension was diluted 1:200 in broth medium (e.g., CAMHB with 0.0025% NADH and 1% sterile ﬁltered
heat-inactivated chicken serum) to yield an inoculum density of approximately 5  105 CFU/ml. A
volume of 50 l of this suspension was added to each well of the microtiter plates. Reading of microtiter
TABLE 5 Test ranges of antimicrobial agents included in this study
Antimicrobial agent Range (g/ml)
Ampicillin 0.03–64
Amoxicillin-clavulanic acid (2:1 ratio) 0.03/0.015–64/32
Ceftiofur 0.03–64
Cefquinome 0.015–32
Cefoperazone 0.06–32
Cefotaxime 0.015–32
Ciproﬂoxacin 0.006–16
Colistin 0.03–16
Doxycycline 0.06–128
Enroﬂoxacin 0.008–16
Florfenicol 0.12–256
Gentamicin 0.12–256
Imipenem 0.015–32
Nalidixic acid 0.06–128
Neomycin 0.03–128
Penicillin 0.015–32
Streptomycin 0.25–256
Tiamulin 0.03–64
Tetracycline 0.12–128
Tilmicosin 0.06–64
Trimethoprim-sulfamethoxazole (1:19 ratio) 0.015/0.3–32/608
Haemophilus parasuis Susceptibility Testing Method Journal of Clinical Microbiology
January 2017 Volume 55 Issue 1 jcm.asm.org 271
 o
n
 June 14, 2017 by UQ Library
http://jcm.asm.org/
D
ow
nloaded from
 
plates was done visually after 16 to 20 h and 24 h of incubation of plates in an ambient-air incubator.
An inoculum density of approximately 5  105 CFU/ml was veriﬁed by inoculum control as described in
document M07-A9. To assess the homogeneity of MICs, broth microdilution susceptibility testing was
performed in ﬁve replicates. The quality control strains Escherichia coli (ATCC 25922), Enterococcus faecalis
(ATCC 29212), Staphylococcus aureus (ATCC 29213), and A. pleuropneumoniae (ATCC 27090) served for
quality control procedures along with their CLSI-recommended media (17, 24).
When comparing MICs generated in TMB and supplemented CAMHB, all 47 H. parasuis isolates were
used.
Data evaluation and statistical analysis. The primary aims of this study were the exploration of
MICs and the investigation of differences in MICs when using two different media (supplemented CAMHB
and TMB). Of secondary interest was a comparison of the stability of MICs after 16 to 20 h and 24 h of
incubation.
To investigate whether the stability of the MICs differed between the two incubation times, for each
combination of isolate, medium, antibiotic agent and incubation time, MIC data received from ﬁve
measurements were summarized to a dichotomous outcome. Evaluation was done by taking one model
with two variables (precondition of ﬁve identical MICs, here referred to as exact MIC agreement, and MIC
mode accepting a deviation of1 dilution step, referred to as essential MIC agreement, respectively) into
consideration. The outcome was set to 1 if preconditions were fulﬁlled according to the variable and 0
otherwise. Stability of measurements was analyzed based on this outcome with a multifactorial logistic
regression model depending on isolate, medium, antibiotic agent, and incubation time. Differences in
MICs depending on incubation time were investigated with an analysis of variance (ANOVA) model,
modeling the log-transformed MICs depending on the four factors. Due to the distribution of MICs being
skewed to the right and a 2-fold dilution series being used, data were log transformed to the base 2. The
media were compared separately for antibiotic agents using the two-sided one-sample t test for the
differences between the two media. Due to the explorative nature of the experiments, no multiple
adjustments were performed and comparison-wise P values were reported. When analyzing the data,
antimicrobial agents were omitted from statistical analysis when more than 50% of isolates had a MIC at
the lowest concentration tested. Statistical analyses were carried out using SAS software, version 9.3 (SAS
Institute, Cary, NC) (25).
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